Research Topics
| P MoayyediSummaryAffiliation: McMaster University Country: Canada Publications
| Collaborators
|
Detail Information
Publications
DyspepsiaPaul Moayyedi
Division of Gastroenterology, McMaster University, Hamilton, Canada
Curr Opin Gastroenterol 28:602-7. 2012..pylori. Patients who remain symptomatic with this strategy may be investigated with endoscopy, but most will have functional dyspepsia...
The impact of intensifying acid suppression on sleep disturbance related to gastro-oesophageal reflux disease in primary careP Moayyedi
Division of Gastroenterology, McMaster University, Hamilton, ON, Canada
Aliment Pharmacol Ther 37:730-7. 2013..Sleep disturbance is common in patients with GERD but there has been little evaluation of this problem in primary care in patients already taking therapy...
The risks of PPI therapyPaul Moayyedi
Division of Gastroenterology, Department of Medicine, McMaster University, 1280 Main Street West, HSC room 4W8E, Hamilton, ON L8S 4K1, Canada
Nat Rev Gastroenterol Hepatol 9:132-9. 2012..As with any therapy, therefore, it is advisable to prescribe PPIs only to patients for whom these drugs have been proven beneficial...
Sequential regimens for Helicobacter pylori eradicationPaul Moayyedi
Division of Gastroenterology, Department of Medicine, McMaster University Medical Centre, Hamilton, ON, Canada L8N 3Z5
Lancet 370:1010-2. 2007
Economic reflections on proton pump inhibitor therapy for non-erosive reflux diseasePaul Moayyedi
Division of Gastroenterology, Department of Medicine, McMaster University Medical Centre, Hamilton, Ont, Canada
Digestion 78:61-9. 2008..PPI therapy is also likely to be a cost-effective strategy for non-erosive reflux disease at generic but not at proprietary prices...
Association between Helicobacter pylori infection and adult heightPaul Moayyedi
AstraZeneca Richard Hunt Chair of Gastroenterology, Department of Medicine, McMaster University, 1200 Main St W, HSC 3N51D Hamilton, Ontario, Canada
Eur J Epidemiol 20:455-65. 2005..A cross-sectional survey was performed to evaluate the association between H. pylori and adult height...
Review article: gastro-oesophageal reflux disease--the extent of the problemP Moayyedi
Department of Medicine, Division of Gastroenterology, McMaster University Medical Centre, Hamilton, ON, Canada
Aliment Pharmacol Ther 22:11-9. 2005..Reflux symptoms were less common in East Asian populations with only 7% having heartburn at least once per month. Heartburn is a significant problem in Western societies...
Helicobacter pylori public health implicationsPaul Moayyedi
Department of Medicine, Gastroenterology Division, McMaster University, Hamilton, Ontario L8N 3Z5, Canada
Helicobacter 9:67-72. 2004..The medical community should be consistent and if we are instituting other population screening programmes without randomized controlled trial evidence then H. pylori testing and treatment should also be considered...
Should we test for Helicobacter pylori before treating gastroesophageal reflux disease?Paul Moayyedi
Division of Gastroenterology, McMaster University, Hamilton, Ontario, Canada
Can J Gastroenterol 19:425-7. 2005..23 to 0.32). H. pylori eradication is therefore recommended in children with GERD that are having an endoscopy. However, when the diagnosis of GERD is being made clinically or by pH monitoring, it is not necessary to screen for H. pylori...
The efficacy of proton pump inhibitors in nonulcer dyspepsia: a systematic review and economic analysisPaul Moayyedi
Gastroenterology Division, McMaster University, Hamilton, Ontario, Canada
Gastroenterology 127:1329-37. 2004..We conducted a systematic review to evaluate whether PPI therapy had any effect in nonulcer dyspepsia and constructed a health economic model to assess the cost-effectiveness of this approach...
The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic reviewP Moayyedi
Department of Medicine, Division of Gastroenterology, McMaster University Medical Centre, 1200 Main Street West, HSC 4W8E, Hamilton, ON L8N 3Z5, Canada
Gut 59:325-32. 2010..Probiotics may benefit irritable bowel syndrome (IBS) symptoms, but randomised controlled trials (RCTs) have been conflicting; therefore a systematic review was conducted...
Can the clinical history distinguish between organic and functional dyspepsia?Paul Moayyedi
Department of Medicine, McMaster University, Hamilton, Ontario, Canada
JAMA 295:1566-76. 2006..Upper gastrointestinal symptoms occur in 40% of the population. An accurate diagnosis would help rationalize investigation and treatment...
The epidemiology of obesity and gastrointestinal and other diseases: an overviewPaul Moayyedi
Division of Gastroenterology, Department of Medicine, McMaster University Medical Centre, 1200 Main Street West, Hamilton, Ontario, Canada
Dig Dis Sci 53:2293-9. 2008..Although the exact cause remains uncertain, these symptoms may be connected to eating habits or to changes in gastrointestinal motility...
Colorectal cancer screening lacks evidence of benefitPaul Moayyedi
Division of Gastroenterology, McMaster University, Hamilton, Ontario, Canada
Cleve Clin J Med 74:545, 549-50, 552 passim. 2007..Whether this phenomenon is due to anxiety, test bias, or merely chance, more evidence is needed; widespread screening in the general population is premature...
Symptom-based diagnostic criteria for irritable bowel syndrome: the more things change, the more they stay the samePaul Moayyedi
Division of Gastroenterology, Farncombe Family Digestive Health Research Institute, Department of Medicine, McMaster University Medical Centre, 1200 Main Street West, HSC room 4W8E, Hamilton, ON, L8N 3Z5 Canada
Gastroenterol Clin North Am 40:87-103. 2011..However, the most common causes of symptoms of the gastrointestinal tract are functional. It is important that clinicians obtain a thorough history so that the disorder of the patient can be accurately defined...
The gain in quality-adjusted life months by switching to esomeprazole in those with continued reflux symptoms in primary care: EncomPASS--a cluster-randomized trialPaul Moayyedi
Division of Gastroenterology, Department of Medicine, McMaster University Medical Centre, Hamilton, Ontario, Canada
Am J Gastroenterol 105:2341-6. 2010..We expressed the data in terms of cost per quality-adjusted life months (QALM), as this was a 4-week trial...
The health economics of Helicobacter pylori infectionPaul Moayyedi
Division of Gastroenterology, McMaster University Medical Centre, 1200 Main Street West, HSC room 4W8E, Hamilton, ON L8N 3Z5, Canada
Best Pract Res Clin Gastroenterol 21:347-61. 2007..RCTs have suggested this approach may be cost saving but more data are needed on whether H. pylori eradication will reduce gastric cancer mortality before this strategy can be recommended...
Mortality rates in patients with Barrett's oesophagusP Moayyedi
Division of Gastroenterology, Department of Medicine, McMaster University, Hamilton, ON, Canada
Aliment Pharmacol Ther 27:316-20. 2008..Patients with Barrett's oesophagus are at increased risk of oesophageal adenocarcinoma. Observational studies have suggested increase in overall mortality also but data are conflicting...
Meta-analysis: Helicobacter pylori'test and treat' compared with empirical acid suppression for managing dyspepsiaA C Ford
Division of Gastroenterology, McMaster University, Health Sciences Centre, Hamilton, ON, Canada
Aliment Pharmacol Ther 28:534-44. 2008..Aim To conduct an individual patient data meta-analysis of randomized controlled trials (RCTs) of 'test and treat' vs. empirical acid suppression in adults with uncomplicated dyspepsia in primary care...
Efficacy of antidepressants and psychological therapies in irritable bowel syndrome: systematic review and meta-analysisA C Ford
Gastroenterology Division, McMaster University Medical Centre, 1200 Main Street West, Hamilton, Ontario, L8N 3Z5, Canada
Gut 58:367-78. 2009..Irritable bowel syndrome (IBS) is a chronic functional gastrointestinal disorder. Evidence for treatment of the condition with antidepressants and psychological therapies is conflicting...
Prevalence of uninvestigated dyspepsia 8 years after a large waterborne outbreak of bacterial dysentery: a cohort studyAlexander C Ford
Department of Medicine, Division of Gastroenterology, and Farncombe Family Digestive Health Research Institute, McMaster University, Hamilton, Ontario, Canada
Gastroenterology 138:1727-36; quiz e12. 2010..We assessed prevalence of uninvestigated dyspepsia in a cohort of individuals, some of whom were exposed to bacterial dysentery in May 2000, as well as risk factors for dyspepsia in exposed individuals...
Canadian Helicobacter Study Group Consensus Conference: Update on the approach to Helicobacter pylori infection in children and adolescents--an evidence-based evaluationBilly Bourke
Division of GI Nutrition, The Hospital for Sick Children, Department of Paediatrics, University of Toronto, Ontario, Canada
Can J Gastroenterol 19:399-408. 2005..pylori infection in children is 14 days; and H. pylori culture and antibiotic sensitivity testing should be made available to monitor population antibiotic resistance and manage treatment failures...
Diagnostic utility of alarm features for colorectal cancer: systematic review and meta-analysisA C Ford
Gastroenterology Division, McMaster University, Health Sciences Centre, 1200 Main Street West, Hamilton, Ontario, Canada
Gut 57:1545-53. 2008..Alarm features are used to prioritize access to urgent investigation, but there is little information concerning their utility in the diagnosis of colorectal cancer...
Eight year prognosis of postinfectious irritable bowel syndrome following waterborne bacterial dysenteryJohn K Marshall
Division of Gastroenterology, McMaster University Medical Centre, 1200 Main Street West, Hamilton, Ontario, Canada
Gut 59:605-11. 2010....
Canadian Consensus Conference on the management of gastroesophageal reflux disease in adults - update 2004David Armstrong
Division of Gastroenterology, McMaster University, Hamilton
Can J Gastroenterol 19:15-35. 2005..Since the last Canadian Consensus Conference in 1996, GERD management has evolved substantially...
Cost-utility and cost-benefit analyses: how did we get here and where are we going?Paul Moayyedi
Gastroenterology Division, McMaster University, Hamilton, Ontario, Canada and Centre for Health Services Research, University of Newcastle upon Tyne, UK
Eur J Gastroenterol Hepatol 16:527-34. 2004..The results of cost-benefit analysis may provide more transparent guidance for policy makers, doctors and patients...
Should patients with GERD be screened once at least for Barrett's epithelium? Con: Patients with GERD should be screened once at least for Barrett's esophagus--medicine or magic?Paul Moayyedi
Gastroenterology Division, Department of Medicine, McMaster University, Hamilton, Ontario
Am J Gastroenterol 99:2293-5. 2004
Adverse events with bismuth salts for Helicobacter pylori eradication: systematic review and meta-analysisAlexander C Ford
Gastroenterology Division, McMaster University Medical Centre, 1200 Main Street West, Hamilton, Ontario L8N 3Z5, Canada
World J Gastroenterol 14:7361-70. 2008..To assess the safety of bismuth used in Helicobacter pylori (H pylori) eradication therapy regimens...
Canadian consensus guidelines on long-term nonsteroidal anti-inflammatory drug therapy and the need for gastroprotection: benefits versus risksA Rostom
Division of Gastroenterology, University of Calgary Medical Clinic, AB, Canada
Aliment Pharmacol Ther 29:481-96. 2009..Nonsteroidal anti-inflammatory drugs (NSAIDs) are widely used, but are not without risks...
Meta-analysis: yield of diagnostic tests for coeliac disease in dyspepsiaA C Ford
Gastroenterology Division, McMaster University, Health Sciences Centre, Hamilton, ON, Canada
Aliment Pharmacol Ther 30:28-36. 2009..The prevalence of coeliac disease (CD) may be increased in individuals with dyspepsia, but evidence is conflicting...
Genetic risk factors for post-infectious irritable bowel syndrome following a waterborne outbreak of gastroenteritisAlexandra Chloe Villani
Division of Gastroenterology, Department of Medicine, McGill University, Montreal, Quebec, Canada
Gastroenterology 138:1502-13. 2010..2% of these developed IBS. We used this cohort to study genetic susceptibility to post-infectious (PI)-IBS...
Gastro-oesophageal reflux diseasePaul Moayyedi
Department of Medicine, Division of Gastroenterology, McMaster University Medical Centre, Hamilton, ON, Canada
Lancet 367:2086-100. 2006..The role of endoscopic therapy is uncertain. Anti-reflux surgery is probably as effective as PPI therapy although there is a low operative mortality and morbidity...
Systematic review and meta-analysis of the prevalence of irritable bowel syndrome in individuals with dyspepsiaAlexander C Ford
Gastroenterology Division, McMaster University, Health Sciences Centre, Hamilton, Ontario, Canada
Clin Gastroenterol Hepatol 8:401-9. 2010..Dyspepsia and irritable bowel syndrome (IBS) are common conditions that can coexist in patients. We performed a systematic review and meta-analysis to estimate prevalence of IBS in dyspepsia...
Does fecal occult blood testing really reduce mortality? A reanalysis of systematic review dataPaul Moayyedi
Gastroenterology Division, Department of Medicine, McMaster University, Hamilton, Ontario, Canada
Am J Gastroenterol 101:380-4. 2006..Systematic reviews suggest that FOBT is effective in reducing CRC mortality but the data on overall mortality from any cause has rarely been synthesized...
Efficacy of 5-HT3 antagonists and 5-HT4 agonists in irritable bowel syndrome: systematic review and meta-analysisAlexander C Ford
Gastroenterology Division, McMaster University, Health Sciences Center, Hamilton, Ontario, Canada
Am J Gastroenterol 104:1831-43; quiz 1844. 2009..We conducted a systematic review and meta-analysis of randomized controlled trials (RCTs) to estimate the efficacy of all available 5-HT agents in IBS...
New approaches to enhance the accuracy of the diagnosis of reflux diseaseP Moayyedi
Gastroenterology Division, McMaster University, Ontario, Canada
Gut 53:iv55-7. 2004..There will be some bias in the type of patient referred for diagnosis and this usually decreases the specificity of symptom diagnosis...
Bringing science to the art of diagnosisP Moayyedi
Gastroenterology Division, McMaster University-HSC 4W8, Hamilton, Ontario, Canada L8N 3Z5
Gut 53:627-8. 2004
Hip fracture and proton pump inhibitor therapy: balancing the evidence for benefit and harmPaul Moayyedi
Division of Gastroenterology, Department of Medicine, McMaster University, Hamilton, Ontario, Canada
Am J Gastroenterol 103:2428-31. 2008..The association between proton pump inhibitor therapy and hip fracture is a good illustration of this dilemma. We use this example to highlight an approach that can be taken to critically evaluate the evidence for harms of medication...
Yield of diagnostic tests for celiac disease in individuals with symptoms suggestive of irritable bowel syndrome: systematic review and meta-analysisAlexander C Ford
MB MRCP, Gastroenterology Division, McMaster University, Health Sciences Centre, 1200 Main St W, Hamilton, ON L8N 3Z5, Canada
Arch Intern Med 169:651-8. 2009..Studies suggest that the prevalence of celiac disease is increased in individuals with IBS; however, evidence is conflicting, and current guidelines do not always recommend screening for celiac disease in these individuals...
Will the history and physical examination help establish that irritable bowel syndrome is causing this patient's lower gastrointestinal tract symptoms?Alexander C Ford
Gastroenterology Division, McMaster University Medical Centre, 1200 Main St W, Hamilton, ON L8N 3Z5, Canada
JAMA 300:1793-805. 2008..These individuals are frequently diagnosed with irritable bowel syndrome (IBS) based on their symptoms; however, some may require additional testing or referral to specialists before this diagnosis is made...
Systematic review of the risk of enteric infection in patients taking acid suppressionJennifer Leonard
Department of Medicine, Division of Gastroenterology, McMaster University, Hamilton, Ontario, Canada
Am J Gastroenterol 102:2047-56; quiz 2057. 2007..There have been concerns raised about the possible association of PPIs with enteric infections...
Effect of fibre, antispasmodics, and peppermint oil in the treatment of irritable bowel syndrome: systematic review and meta-analysisAlexander C Ford
Gastroenterology Division, McMaster University, Health Sciences Centre, 1200 Main Street West, Hamilton, ON, L8N 3Z5, Canada
BMJ 337:a2313. 2008..To determine the effect of fibre, antispasmodics, and peppermint oil in the treatment of irritable bowel syndrome...
Is it safe to use a proton pump inhibitor with clopidogrel?Clara K Chow
Population Health Research Institute, David Braley Cardiac, Vascular and Stroke Research Institute, Hamilton General Hospital, Hamilton, ON, Canada
Pol Arch Med Wewn 119:564-8. 2009..As both drugs have very short half-lives, taking them with a large time gap between drugs (e.g., morning and night) may theoretically decrease the chance of interaction...
Errors in the conduct of systematic reviews of pharmacological interventions for irritable bowel syndromeAlexander C Ford
Gastroenterology Division, Health Sciences Center, McMaster University, Hamilton, Ontario, Canada
Am J Gastroenterol 105:280-8. 2010..Although flawed systematic reviews could compromise optimal decision making, their accuracy has received limited investigation. We assessed conduct of systematic reviews of pharmaceutical interventions for irritable bowel syndrome (IBS)...
Meta-analysis: Can we mix apples and oranges?Paul Moayyedi
Department of Medicine, Gastroenterology Division, McMaster University, Hamilton, Ontario, Canada
Am J Gastroenterol 99:2297-301. 2004
International consensus recommendations on the management of patients with nonvariceal upper gastrointestinal bleedingAlan N Barkun
Division of Gastroenterology, Montreal General Hospital Site, McGill University Health Centre, Montreal, Quebec, Canada
Ann Intern Med 152:101-13. 2010..A multidisciplinary group of 34 experts from 15 countries developed this update and expansion of the recommendations on the management of acute nonvariceal upper gastrointestinal bleeding (UGIB) from 2003...
International comparisons of manpower in gastroenterologyPaul Moayyedi
Department of Medicine, Division of Gastroenterology, McMaster University Medical Centre, Hamilton, Ontario, Canada
Am J Gastroenterol 102:478-81. 2007..The United States had the most variation in the number of gastroenterologists per 100,000 of the population among states...
Small intestinal bacterial overgrowth in irritable bowel syndrome: systematic review and meta-analysisAlexander C Ford
Gastroenterology Division, McMaster University, Health Sciences Centre, Hamilton, Ontario, Canada
Clin Gastroenterol Hepatol 7:1279-86. 2009..Small intestinal bacterial overgrowth (SIBO) has been proposed as an etiologic factor in irritable bowel syndrome (IBS), but evidence is conflicting. We conducted a systematic review and meta-analysis of the prevalence of SIBO in IBS...
Irritable bowel syndrome: a 10-yr natural history of symptoms and factors that influence consultation behaviorAlexander C Ford
Centre for Digestive Diseases, Leeds General Infirmary, Great George Street, Leeds, United Kingdom
Am J Gastroenterol 103:1229-39; quiz 1240. 2008..The natural history of the condition has been studied extensively, but few studies have examined factors that predict its new onset or health care-seeking behavior...
Esophageal adenocarcinoma arising from Barrett's metaplasia has regional variations in the westJanusz A Jankowski
Gastroenterology 122:588-90. 2002
Gastric Cancer Consensus conference recommends Helicobacter pylori screening and treatment in asymptomatic persons from high-risk populations to prevent gastric cancerNicholas J Talley
Department of Internal Medicine and Division of Gastroenterology and Hepatology, Mayo Clinic, Jacksonville, Florida 32224, USA
Am J Gastroenterol 103:510-4. 2008..pylori in particularly high-risk population settings. The evidence for these recommendations is summarized in this report, and the global and U.S. implications are considered...
Current guidelines for dyspepsia managementAlexander C Ford
Department of Academic Medicine, St James s University Hospital, Leeds, UK
Dig Dis 26:225-30. 2008..This article compares and contrasts dyspepsia management guidelines from several geographical regions...
Asia-Pacific consensus guidelines on gastric cancer preventionKwong Ming Fock
Changi General Hospital, Singapore
J Gastroenterol Hepatol 23:351-65. 2008..Gastric cancer is a major health burden in the Asia-Pacific region but consensus on prevention strategies has been lacking. We aimed to critically evaluate strategies for preventing gastric cancer...
Helicobacter pylori test and treat versus proton pump inhibitor in initial management of dyspepsia in primary care: multicentre randomised controlled trial (MRC-CUBE trial)Brendan C Delaney
Primary Care Clinical Sciences, University of Birmingham, Birmingham B15 2TT
BMJ 336:651-4. 2008..To determine the cost effectiveness of Helicobacter pylori "test and treat" compared with empirical acid suppression in the initial management of patients with dyspepsia in primary care...
Management of Barrett's esophagus in the UK: overtreated and underbiopsied but improved by the introduction of a national randomized trialDebasish Das
Digestive Disease Centre, Leicester Royal Infirmary, Leicester, UK
Am J Gastroenterol 103:1079-89. 2008....
Helicobacter pylori eradication therapy for nonulcer dyspepsiaPaul Moayyedi
Ann Intern Med 136:555-6; author reply 555-6. 2002
Helicobacter pylori eradication has the potential to prevent gastric cancer: a state-of-the-art critiquePeter Malfertheiner
Department of Gastroenterology, Hepatology and Infectious Diseases, Otto-von-Guericke University, Magdeburg, Germany
Am J Gastroenterol 100:2100-15. 2005..pylori-associated diseases...
Ethnicity, gender, and socioeconomic status as risk factors for esophagitis and Barrett's esophagusAlexander C Ford
Centre for Digestive Diseases, Leeds General Infirmary, Leeds, United Kingdom
Am J Epidemiol 162:454-60. 2005..35) and of higher socioeconomic status (adjusted OR=1.58, 95% CI: 1.16, 2.15 (top tertile vs. bottom tertile)). White Caucasian ethnicity, male gender, and higher socioeconomic status are independent risk factors for Barrett's esophagus...
Helicobacter pylori "test and treat" or endoscopy for managing dyspepsia: an individual patient data meta-analysisAlexander C Ford
Centre for Digestive Diseases, Leeds General Infirmary, United Kingdom
Gastroenterology 128:1838-44. 2005..CONCLUSIONS: Prompt endoscopy confers a small benefit in terms of cure of dyspepsia but costs more than "test and treat" and is not a cost-effective strategy for the initial management of dyspepsia...
Dyspepsia results may not apply in primary careBrendan C Delaney
BMJ 327:811. 2003
An update of the Cochrane systematic review of Helicobacter pylori eradication therapy in nonulcer dyspepsia: resolving the discrepancy between systematic reviewsPaul Moayyedi
Gastroenterology Unit, Health Services Research, The City Hospital NHS Trust, Dudley Road, Winston Green, Birmingham B18 7QH, U.K
Am J Gastroenterol 98:2621-6. 2003..There is evidence for a small benefit of eradicating H. pylori in nonulcer dyspepsia, and this is confirmed by updating the Cochrane systematic review...
Symptom-based outcome measures for dyspepsia and GERD trials: a systematic reviewAdam Fraser
Department of Primary Care and General Practice, Primary Care Clinical Sciences Building, The University of Birmingham, Edgbaston, Birmingham, UK
Am J Gastroenterol 100:442-52. 2005..Further research is necessary to compare existing outcome measures to determine which are the most reliable, valid, and responsive instruments...
Re: Cost-effectiveness of aspirin chemoprevention for Barrett's esophagusJanusz Jankowski
J Natl Cancer Inst 96:885-7; author reply 887. 2004
Cost-effectiveness and long-term impact of Helicobacter pylori 'test and treat' service in reducing open access endoscopy referralsAravamuthan Sreedharan
Department of Gastroenterology, Centre for Digestive Diseases, The General Infirmary at Leeds, UK
Eur J Gastroenterol Hepatol 16:981-6. 2004....
Eradication therapy in Helicobacter pylori positive peptic ulcer disease: systematic review and economic analysisAlexander C Ford
Centre for Digestive Diseases, Leeds General Infirmary, Great George Street, Leeds, UK
Am J Gastroenterol 99:1833-55. 2004..CONCLUSIONS: H. pylori eradication therapy reduces the recurrence of peptic ulcer disease and is cost-effective...
How can the current strategies for Helicobacter pylori eradication therapy be improved?Alex Ford
Gastroenterology Unit, City Hospital National Health Service Trust, Dudley Road, Winston Green, Birmingham B18 7QH, United Kingdom
Can J Gastroenterol 17:36B-40B. 2003..The use of Helicobacter pylori eradication therapy is advocated in an increasing variety of situations. It is therefore important to optimise current strategies to eradicate H pylori infection...
A community screening program for Helicobacter pylori saves money: 10-year follow-up of a randomized controlled trialAlexander C Ford
Centre for Digestive Diseases, Leeds General Infirmary, Leeds, United Kingdom
Gastroenterology 129:1910-7. 2005..89; 95% CI: 0.77-1.03). CONCLUSIONS: There were significant reductions in total dyspepsia-related health care costs. The savings made were greater than the initial cost of H pylori screening and treatment...
Helicobacter pylori infectionBrendan C Delaney
University of Birmingham, Birmingham, United Kingdom
Am Fam Physician 67:2359-60. 2003
A second-order simulation model of the cost-effectiveness of managing dyspepsia in the United StatesPelham M Barton
Health Economics Facility, University of Birmingham, UK
Med Decis Making 28:44-55. 2008..The objective of this study was to explore uncertainty in controversial areas of the 2005 American Gastroenterology Association position statement on the management of dyspepsia...
Effect of sibling number in the household and birth order on prevalence of Helicobacter pylori: a cross-sectional studyAlexander C Ford
Centre for Digestive Diseases, Leeds General Infirmary, Great George Street, Leeds, UK
Int J Epidemiol 36:1327-33. 2007..pylori) is acquired mainly in childhood, with studies demonstrating this is related to living conditions. Effects of sibling number and birth order on prevalence of infection have not been extensively studied...
Relation of adult lifestyle and socioeconomic factors to the prevalence of Helicobacter pylori infectionPaul Moayyedi
Centre for Digestive Diseases, The General Infirmary at Leeds, UK
Int J Epidemiol 31:624-31. 2002..The influence of adult socioeconomic status, co-habitation, gender, smoking, coffee and alcohol intake on risk of Helicobacter pylori infection is uncertain...
Barrett's esophagus and obesity: the missing part of the puzzlePaul Moayyedi
Am J Gastroenterol 103:301-3. 2008..In particular, more research is needed on visceral adipose tissue and risk of esophageal adenocarcinoma, and whether obesity is an important risk factor for the development of neoplasia in those with Barrett's esophagus...
Helicobacter pylori and nonmalignant diseasePaul Moayyedi
City Hospital NHS Trust, Winson Green, Birmingham, UK
Helicobacter 7:30-6. 2002..Finally important new data are presented regarding the management of dyspepsia at the primary care level with the confirmation that the H. pylori 'test and treat' strategy in the appropriate setting is more cost-effective than endoscopy...
Recent developments in gastroenterologyPaul Moayyedi
Gastroenterology Unit, City Hospital NHS Trust, Birmingham B18 7QH
BMJ 325:1399-402. 2002
Initial poor quality of life and new onset of dyspepsia: results from a longitudinal 10-year follow-up studyAlexander C Ford
Department of Academic Medicine, Clinical Sciences Building, St James s University Hospital, Leeds, UK
Gut 56:321-7. 2007..However, few have reported the effect of quality of life on the development of dyspepsia. A 10-year longitudinal follow-up study examining the effect of quality of life on subsequent dyspepsia was performed...
Colorectal cancer screening with fecal occult blood testing (FOBT): an international perspectiveEdgar Achkar
Am J Gastroenterol 101:212. 2006
Eradicating H pyloriBrendan Delaney
BMJ 328:1388-9. 2004
Establishing patient preferences for gastroenterology clinic reorganization using conjoint analysisPaul Moayyedi
Gastroenterology Health Services Research, City Hospital NHS Trust, Dudley Road, Winson Green, Birmingham B18 7QH, UK
Eur J Gastroenterol Hepatol 14:429-33. 2002..Decisions such as these are often made with little assessment of patient preferences. We have elicited patient preferences for the optimal use of time in the outpatient clinic...
A systematic review of psychological therapies for nonulcer dyspepsiaShelly Soo
South Tyneside District Hospital, South Shields, Tyne and Wear, U.K
Am J Gastroenterol 99:1817-22. 2004..CONCLUSIONS: There was insufficient evidence on the efficacy of psychological therapies in NUD. This emphasizes the need for appropriately powered well-designed trials in this area...
The promises and perils of nurse-led flexible sigmoidoscopy screeningPaul Moayyedi
Can J Gastroenterol 21:280-2. 2007
Detection of intestinal metaplasia in Barrett's esophagus: an observational comparator study suggests the need for a minimum of eight biopsiesRebecca Harrison
Digestive Diseases Center, University Hospitals of Leicester, Leicester UK
Am J Gastroenterol 102:1154-61. 2007..We aimed to assess the frequency of intestinal metaplasia in 125 consecutive patients with columnar-lined esophagus and to determine the optimal biopsy protocol to detect intestinal metaplasia...
Endoscopic screening and surveillance for Barrett's esophagus--clinical implicationsHugh Barr
Cranfield Postgraduate Medical School, Gloucestershire, Gloucestershire Royal Hospital, Gloucester, United Kingdom
MedGenMed 8:88. 2006..The detection of dysplasia requires increased surveillance and usually intervention either endoscopically or with surgery...
Endoscopic screening and surveillance for Barrett's esophagus--clinical implicationsHugh Barr
Cranfield Postgraduate Medical School in Gloucestershire, Gloucestershire Royal Hospital, Gloucester, United Kingdom
MedGenMed 8:66. 2006..The detection of dysplasia requires increased surveillance and usually intervention either endoscopically or with surgery...
NSAID and oesophageal adenocarcinoma: randomised trials needed to correct for biasJanusz Jankowski
Lancet Oncol 7:7-8; author reply 8-9. 2006
American gastroenterological association technical review on the evaluation of dyspepsiaNicholas J Talley
Division of Gastroenterology and Hepatology and Internal Medicine, Mayo Clinic College of Medicine, Rochester, Minnesota
Gastroenterology 129:1756-80. 2005
Diagnostic and therapeutic use of proton pump inhibitors in non-cardiac chest pain: a metaanalysisFilippo Cremonini
Clinical Enteric Neuroscience, Translational and Epidemiological Research Program (C.E.N.T.E.R.) and Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA
Am J Gastroenterol 100:1226-32. 2005..All studies were small and there was evidence of publication bias or other small study effects. CONCLUSION: PPI therapy reduces symptoms in NCCP and may be useful as a diagnostic test in identifying abnormal esophageal acid reflux...
Gambling with gastroesophageal reflux disease: should we worry about the QALY?Paul Moayyedi
Am J Gastroenterol 100:534-6. 2005..Comparing health care in terms of cost per quality adjusted life year (QALY) gained is one approach to this problem although there are concerns about whose values should be elicited and how QALYs are measured...
Measuring gastroesophageal reflux symptoms: musings from MarrakechPaul Moayyedi
Am J Gastroenterol 100:19-20. 2005..This has important implications for the development of future questionnaires in gastroesophageal reflux and other gastrointestinal diseases...
Who consults with dyspepsia? Results from a longitudinal 10-yr follow-up studyAlexander C Ford
Centre for Digestive Diseases, Leeds General Infirmary, Leeds, United Kingdom
Am J Gastroenterol 102:957-65. 2007..Dyspepsia is common, and the condition is often chronic, with a relapsing and remitting nature. Factors influencing the decision to consult a physician with symptoms remain unclear...
